Melanoma Foundation of New England Educational Symposium
Patients, survivors, families and friends are invited to join us for an evening of education, and discussion surrounding immunotherapy. Refreshments will be provided. Free parking at the Yawkey Garage, 1 Jimmy Fund Way.
Elizabeth Buchbinder, MD
Dana Farber Cancer Institute
Dr. Elizabeth Buchbinder is a clinical oncologist at Dana Farber Cancer Institute specializing in the treatment of melanoma. She also performs clinical and translational research to help further melanoma treatment. Her research interests include immunotherapy, targeted therapy and early drug development. In addition she works closely with basic scientists within Dana Farber Cancer institute to perform analysis on patient samples which help guide future therapeutic approaches. She obtained her MD at Tufts University and her medical training at Beth Israel Deaconess Medical Center and is currently a part of the Melanoma Disease Center at Dana Farber Cancer Institute.
Justine Cohen, DO
Massachusetts General Hospital
Justine V. Cohen is a medical oncologist at the Massachusetts General Hospital specializing in melanoma. She received her undergraduate education at Yale University and earned her medical degree from the Philadelphia College of Osteopathic Medicine. After completing an Internal Medicine residency and Chief Residency at Pennsylvania Hospital of the University of Pennsylvania, she pursued fellowship training in Hematology and Oncology at Yale. Dr. Cohen is a clinical and translational investigator whose specific research interests include the adaptation of promising preclinical findings into new clinical trials, developing new combinations of immune modulating agents for the treatment of alignant melanoma, and the study of immune-related toxicities.